The U.S. Meals and Drug Administration has authorized Dupixent (dupilumab) for the therapy of adults and adolescents with persistent spontaneous…
Read More
The U.S. Meals and Drug Administration has authorized Dupixent (dupilumab) for the therapy of adults and adolescents with persistent spontaneous…
Read More